Originally published In Press as doi:10.1074/jbc.M609399200 on October 30, 2006
J. Biol. Chem., Vol. 282, Issue 2, 1341-1351, January 12, 2007
Substitutions at Methionine 295 of Archaeoglobus fulgidus Ribulose-1,5-bisphosphate Carboxylase/Oxygenase Affect Oxygen Binding and CO2/O2 Specificity*
Nathaniel E. Kreel and
F. Robert Tabita1
From the
Department of Microbiology and the Plant Molecular Biology/Biotechnology Program, Ohio State University, Columbus, Ohio 43210-1292
Received for publication, October 4, 2006
 |
ABSTRACT
|
|---|
Archaeoglobus fulgidus RbcL2, a form III ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco), exhibits unique properties not found in other well studied form I and II Rubiscos, such as optimal activity from 83 to 93 °C and an extremely high kcat value (23 s-1). More interestingly, this protein is unusual in that exposure or assay in the presence of oxygen and high levels of CO2 resulted in substantial loss (85-90%) of activity compared with assays performed under strictly anaerobic conditions. Kinetic studies indicated that A. fulgidus RbcL2 possesses an unusually high affinity for oxygen (Ki = 5 µM); O2 is a competitive inhibitor with respect to CO2, yet the high affinity for O2 presumably accounts for the inability of high levels of CO2 to prevent inhibition. Comparative bioinformatic analyses of available archaeal Rubisco sequences were conducted to provide clues as to why the RbcL2 protein might possess such a high affinity for oxygen. These analyses suggested the potential importance of several unique residues, as did additional analyses within the context of available form I-III Rubisco structures. One residue unique to archaeal proteins (Met-295) was of particular interest because of its proximity to known active-site residues. Recombinant M295D A. fulgidus Rubisco was less sensitive to oxygen compared with the wild-type enzyme. This residue, along with other potential changes in conserved residues of form III Rubiscos, may provide an understanding as to how Rubisco may have evolved to function in the presence of air.
 |
INTRODUCTION
|
|---|
Several eukaryotic and prokaryotic organisms are able to obtain all needed carbon by directly assimilating and reducing CO2. The major mechanism by which CO2 is assimilated in nature is via the Calvin-Benson-Basham (CBB)2 reductive pentose phosphate pathway. There are two unique enzymatic reactions in this pathway that allow CO2 to serve as the sole carbon source for growth. The first of these is catalyzed by ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco), the enzyme that catalyzes the actual CO2 fixation reaction. The other unique enzyme is phosphoribulokinase, which catalyzes the synthesis of the substrate or CO2 acceptor compound for Rubisco, ribulose 1,5-bisphosphate (RuBP). The mechanism of Rubisco catalysis is well defined (1). Briefly, Rubisco initially catalyzes formation of an enediolate intermediate between the second and third carbons of RuBP; this allows for a nucleophilic attack by the gaseous substrate CO2, resulting in the formation of a six-carbon intermediate that is subsequently lysed into two molecules of 3-phosphoglycerate (3-PGA). Alternatively, molecular oxygen may also serve as a gaseous substrate through a similar nucleophilic attack at the same enediol-enzyme complex, forming instead a five-carbon peroxide intermediate that is also subsequently cleaved to form two different products, one molecule of 3-PGA and one molecule of 2-phosphoglycolate (2-PG). The 3-PGA product formed by Rubisco is further utilized in the CBB pathway to regenerate RuBP to supply other carbon intermediates for growth. Unfortunately, the 2-PG product formed as a consequence of O2 fixation to the enediolate intermediate is further oxidatively metabolized, leading to the eventual loss of carbon from the organism, making the oxygenase function of Rubisco inimical to maximizing net CO2 fixation. The relative rates of the competing carboxylase and oxygenase reactions (vc/vo) catalyzed by Rubisco, performed at particular CO2 and O2 concentrations, provide a means to quantify the enzyme's inherent ability to distinguish between the two substrates such that vc/vo =
[CO2]/[O2], where
is the specificity factor. In addition,
= VcKo/VoKc, where (Vmax/Km) reflect the cataytic efficiencies for the carboxylase (Vo/Kc) and oxygenase (Vo/Ko) reactions, respectively.
Rubisco is arguably the most abundant protein on earth (2, 3). This protein plays an important role in the photosynthetic tissue of higher forms of eukaryotic life such as terrestrial plants, but may also be found in lower phototrophic eukaryotes such as green, red, and brown algae and in prokaryotic cyanobacteria and phototrophic eubacteria. Moreover, large numbers of chemoautotrophic prokaryotes, which grow in the absence of light and use dark chemical reactions to provide the energy to support growth, depend on Rubisco and the CBB CO2 fixation pathway (2). Rubisco molecules from these sources have been previously categorized into two groups (forms I and II) based on their sequence homology and structural similarities (2). The form I Rubisco structure is a complex holoenzyme composed of eight large (L; catalytic) subunits and eight small (S) subunits in an (L2)4(S2)4 configuration. The form I enzymes are found in virtually all eukaryotic photosynthetic organisms and also in all cyanobacteria and most eubacteria that use the CBB pathway to assimilate CO2. The form II Rubiscos have a more simple structure, composed solely of large subunits in an (L2)n configuration, which share
25-30% amino acid identity with form I large subunits. Form II proteins are found in various purple photosynthetic bacteria, chemoautotrophs, and eukaryotic marine dinoflagellates (2). The important kinetic constants of diverse forms of Rubisco, particularly
and Kc, differ considerably even among closely related and structurally similar proteins (4, 5); however, there is little molecular understanding as to the basis for this variation. Although all Rubisco proteins conserve key residues for known mechanistically important functions (1, 2), it is apparent that different non-conserved residues and regions of the protein must influence the specificity of the substrates carbon dioxide and oxygen. The focus of engineering a more efficient Rubisco would involve changing the specificity factor of the enzyme by either increasing the carboxylase or decreasing the oxygenase activity or somehow altering the relative affinity for either CO2 or O2 (6). Clearly, before such molecular engineering feats should be considered, it will be most important to understand the factors that mitigate and influence the different kinetic properties of the enzyme.
Recently completed fully sequenced genomes from Archaea have indicated the presence of Rubisco genes in several organisms, although there is no evidence that the CBB reductive pentose phosphate pathway provides a major means by which these organisms assimilate CO2 (7-12). Rather, Rubisco and a novel pathway to synthesize RuBP appear to be used for a type of pyrimidine salvage pathway in methanogenic Archaea (13). Our laboratory has determined that the archaeal Rubisco genes from Archaeoglobus fulgidus, Methanocaldococcus jannaschii, and Methanosarcina acetivorans encode bona fide Rubiscos, capable of catalyzing substantial activity, both in the native organisms as well as within Escherichia coli (11, 12). Moreover, the archaeal genes can be expressed in a phototrophic eubacterial host in which the native Rubisco genes have been inactivated such that the archaeal genes may complement the organism to allow CO2-dependent growth (12). On the basis of sequence homologies, archaeal Rubiscos represent a special class of enzyme, termed form III (2, 14) to distinguish these enzymes from previously characterized form I and II Rubiscos. Even with these considerable differences in primary sequence, the form III enzymes retain many features characteristic of all forms of Rubisco, mainly the ability to carry out carboxylation as a consequence of conservation of the key residues implicated in catalysis (11), as discussed above.
The A. fulgidus rbcL2 gene encodes a protein (RbcL2) of 441 amino acids with a monomer molecular mass of 48.5 kDa. This form III Rubisco exists as a homodimer, as do the enzymes from M. jannaschii and M. acetivorans (11, 12). In this respect, the quaternary structure of the three form III archaeal enzymes resembles the bacterial form II Rubisco from Rhodospirillum rubrum (15). However, A. fulgidus RbcL2 exhibits unique properties not found in other forms of Rubisco such as optimal activity at temperatures exceeding 80 °C. In addition, this protein is highly sensitive yet reversibly inhibited upon exposure to air levels of oxygen, necessitating that the enzyme be prepared under strictly anaerobic conditions to obtain optimal activity. This enzyme is derived from a very strict anaerobe, and like other Rubiscos, there are no motifs that suggest oxygen involvement in stability. In this study, we have focused on this unusual reversible inhibition by low concentrations of oxygen and examined the possible involvement with a unique residue (Met-295) that appears to be located at an influential site within the structure of the protein. The unique oxygen sensitivity of the form III archaeal Rubiscos may provide clues as to how the active site of this enzyme has evolved to become more stable in the presence of oxygen in more evolutionarily advanced form I and II Rubisco proteins.
 |
EXPERIMENTAL PROCEDURES
|
|---|
Plasmids, Bacterial Strains, and Growth ConditionsAll cloning steps were performed in E. coli JM109 (16) prior to transformation into E. coli BL21 (Stratagene, La Jolla, CA) for overexpression of the rbcL2 gene. E. coli cultures were grown in LB medium containing 1% Tryptone, 0.5% yeast extract, and 1% (w/v) NaCl. A. fulgidus rbcL2 (AF_1638, NCBI accession number NC_000917
[GenBank]
) was cloned directly from genomic DNA. Primers designed with an NdeI restriction site (5'-GGAATTCCATATGGCGGAGTTTGAGATTTACAGA-3') at the N terminus and a BamHI restriction site (5'-GCGGATCCTTAGATTGGCGTAACCCTG-3') at the C terminus were used to amplify the rbcL2 gene from A. fulgidus genomic DNA with Pfu polymerase. The gene was ligated into PCR-Script® (Stratagene) and sequenced for PCR-incorporated mutations. The gene was subcloned into pET11a using the NdeI and BamHI sites in that vector.
Site-directed MutagenesisSite-directed mutagenesis was performed using a QuikChange site-directed mutagenesis kit (Stratagene) (17). The Met-295 ATG sequence within the A. fulgidus rbcL2 gene was replaced with GCG, TTC, and GAC to obtain alanine, phenylalanine, and aspartate, respectively, at this position. Automated sequencing was performed to confirm the sequences of mutant genes using a Model 3730 DNA analyzer system (Applied Biosystems, Foster City, CA) at the Ohio State University Plant-Microbe Genomics Facility. The mutant genes were inserted into fresh pET11a plasmid after digestion with NdeI and BamHI.
Overexpression of the rbcL2 Gene and Purification of Recombinant RbcL2 ProteinE. coli BL21 cells were transformed with a pET11a vector containing the A. fulgidus rbcL2 gene, and overnight tube cultures were used to inoculate 2.8-liter broad-bottom flasks containing 2 liters of medium. The cultures were incubated at 37 °C and shaken at 120 rpm to minimize aeration until the culture reached A600 = 0.4. The temperature of the cultures was then raised to 42 °C for 30 min to heat-shock the cultures, resulting in an increase in the amount of soluble recombinant protein (12). The cultures were allowed to cool to room temperature before inducing with 0.1 mM isopropyl
-D-thiogalactopyranoside and allowed to shake at 120 rpm for 16 h at room temperature. Cells were harvested and washed with anaerobic wash buffer (100 mM Bicine-NaOH (pH 8.3), 10 mM MgCl2, and 1 mM EDTA) and placed in an anaerobic chamber. Cells were centrifuged again in anaerobic screw cap centrifuge tubes with rubber seals. Cell pellets were recovered in the chamber and stored at -70 °C before further protein purification.
All subsequent preparation and manipulation of the cell material were performed in an anaerobic chamber. Prior to column chromatography, cells were resuspended in wash buffer supplemented with 10 mM phenylmethylsulfonyl fluoride and 50 µg/ml DNase I and then disrupted using a pressurized French pressure cell (at 110,000 kilopascals) flowing directly into a sealed anaerobic serum vial sparged with argon gas. The lysed cells were then centrifuged at 16,000 x g for 20 min at 4 °C in screw cap centrifuge tubes with rubber seals. The supernatant was decanted into a serum vial, placed in an 80 °C water bath for 20 min, and plunged into an ice bath for 1 h. The heat-stable extract was transferred to a fresh screw cap centrifuge tube with a rubber seal and centrifuged at 30,000 x g for 30 min at 4 °C. The supernatant was syringe-filtered using 0.22-µm filters before loading onto columns.
Column chromatography was performed under anaerobic conditions using a BioLogic HR workstation (Bio-Rad). Heat-stable extract was loaded onto a Q-Sepharose strong anion-exchange column equilibrated with wash buffer supplemented with 50 mM NaHCO3 and 10 mM
-mercaptoethanol (Buffer A). Samples were eluted in a 0-2 M NaCl gradient in Buffer A; recombinant A. fulgidus RbcL2 eluted at
0.4 M NaCl. Fractions were monitored for activity using a modified protocol of the standard Rubisco assay under anaerobic conditions (18). Fractions with high activity were pooled, concentrated with a Millipore concentrator (molecular weight cutoff of 30,000), and loaded onto a 110-ml Superose 12 gel filtration column. Fractions with high activity were again pooled and further purified based on hydrophobic interaction using a phenyl-Sepharose column. Samples were eluted with buffers of decreasing salt content starting with 2 M (NH4)2SO4. Recombinant A. fulgidus RbcL2 was found to elute at
0.4 M (NH4)2SO4. Purified protein was stored in 20% glycerol at -70 °C in anaerobically sealed serum vials.
Radiometric Rubisco AssaysA. fulgidus RbcL2 was assayed for activity under a strictly anaerobic atmosphere unless noted otherwise. The previously described assay was used and modified to optimize carboxylase activity (18). Buffers and substrates were bubbled with argon gas in sealed glass serum vials prior to use. In an anaerobic chamber, enzyme was prepared in glass serum vials in wash buffer supplemented with 0.3 M NaCl. Vials were sealed in the chamber and then placed in a Reacti-Therm IIITM heating/stirring module (Pierce) set at 83 °C after the addition of 50 mM NaHCO3 in Bicine-NaOH buffer containing 2 µCi of NaH14CO3. Reactions were initiated by the addition of anaerobic RuBP and stopped by the addition of aerobic propionic acid. Vials were unsealed and dried overnight in a vacuum oven at 65 °C. Samples were resuspended in 200 µl of 1 N HCl and counted in 3 ml of scintillation mixture using a Tri-Carb 2100TR liquid scintillation analyzer (Packard Instrument Co.). The Bradford method (19) was used to determine protein concentrations with bovine serum albumin as the standard.
Kinetic MeasurementsPurified enzymes were used for all kinetic measurements of kcat, KCO2, KO2KRuBP (Km for RuBP), and
unless noted otherwise. The KCO2 was determined under strictly anaerobic conditions using sealed vials as described previously (20) with few modifications. Dilutions of NaH14CO3 were prepared in 100 mM Bicine-NaOH buffer with 10 mM MgCl2. The pH of the buffer was usually
8.3, and the exact pH was recorded for each assay. Assays were performed at 83 °C, initiated by the addition of anaerobic RuBP, and terminated after 30 s by the addition of aerobic propionic acid. Vials were unsealed and dried overnight in a vacuum oven at 65 °C. Products were resuspended in 1 N HCl and counted in scintillation mixture. Results were plotted using SigmaPlot 2002 (Version 8.0), deriving the KCO2 and KO2 by fitting values to a hyperbolic curve and double-reciprocal plot. The concentration of CO2 was derived using the pH and the Henderson-Hasselbach relationship. The solubility of CO2 at 83 °C was calculated from published values (21) to obtain an equation that was extrapolated to 83 °C. Various concentrations of oxygen were introduced into the vials by removing a certain percent of the anaerobic headspace and replacing it with the same amount of oxygen from a sealed serum vial sparged with pure oxygen. The solubility of oxygen was determined using available solubility charts (Unisense A/S, Aarhus, Denmark). The salinity of the buffer used for each assay was calculated. The amount of soluble oxygen (micromolar) based on the salinity and temperature under the assay conditions was provided by the charts and used in determining the amount of oxygen present in each vial.
The KRuBP was measured as described for the KCO2, determined under strictly anaerobic conditions in sealed serum vials at 83 °C. Various concentrations of RuBP were prepared and sparged with argon gas. Assays were initiated by the addition of RuBP to the assay vials containing activated enzyme; the reaction was stopped after 30 s by the addition of aerobic propionic acid. Samples were dried overnight, resuspended, and counted in scintillation mixture. Results were plotted using SigmaPlot 2002 (Version 8.0).
Specificity was measured under conditions of saturating O2 with 100 mM NaHCO3 in 100 mM Bicine-NaOH buffer (pH 8.3) and 10 mM MgCl2. The concentration of CO2 was calculated from the Henderson-Hasselbach relationship as described above for the KCO2. The solubility of oxygen was determined using available solubility charts as described above. The solubility of CO2 at 83 °C was calculated from published values (21) to obtain an equation that was extrapolated to 83 °C. Reactions were initiated by the addition of [1-3H]RuBP and incubated at 83 °C for 2 h. Reaction products were separated with a Mono Q resin using a Dionex DX500 chromatography system and detected with an in-line scintillation counter (
-RAM, IN/US Systems, Inc., Tampa, FL) as described (22).
Modeling of A. fulgidus RbcL2 was performed using Deep-View Swiss-PdbViewer Version 3.7 (23). The template used to model the dimer form of the enzyme was the Thermococcus kodakaraensis strain KOD1 crystal structure (Protein Data Bank code 1GEH) (24); this is the closest related Rubisco large subunit and is 72% identical at the amino acid level to A. fulgidus RbcL2.
 |
RESULTS
|
|---|
General Properties of A. fulgidus RbcL2It is clear that Rubisco from the Archaea A. fulgidus (RbcL2) may be considered a member of a rather discrete class of proteins that are easily distinguished from the well described form I and II Rubiscos (2, 6, 14, 25, 26). However, the form III A. fulgidus enzyme possesses characteristic Rubisco motifs found in both form I and II Rubisco large subunits (1, 25, 26). More specifically, the A. fulgidus RbcL2 enzyme is a homodimeric protein (12), with each monomer composed of 441 amino acids with a molecular mass of 48.5 kDa. RbcL2 shows 41% amino acid identity to the large subunit of the Synechococcus ssp. strain PCC 6301 Rubisco, a representative form I enzyme, and shows 33% amino acid identity to the R. rubrum enzyme, a typical form II Rubisco. The form I Synechococcus PCC 6301 and form II R. rubrum large subunits exhibit 33% identity to each other. Moreover, among other well studied form III Rubiscos, A. fulgidus RbcL2 shows close sequence (72%) identity to T. kodakaraensis strain KOD1 RbcL, but only 44% identity to M. jannaschii RbcL. The crystal structures of the form I Synechococcus PCC 6301 (Protein Data Bank code 1RBL), form II R. rubrum (code 5RUB), and form III T. kodakaraensis (code 1GEH) Rubiscos have been solved (27-29). Despite overall low sequence homology between representative enzymes from different groups, there is conservation of almost all critical active-site residues that are within 3.3 Å of the bound substrate analog 2-carboxyarabinitol 1,5-bisphosphate within the active site of the Synechococcus PCC 6301 enzyme (28), with the lone exception being position 170 (Fig. 1). It is also clear that what might be termed the Rubisco motif (GXDFXKXDE) is conserved in all Rubiscos, with only the phenylalanine residue within this region replaced with leucine or tyrosine in the form III enzymes from M. jannaschii and A. fulgidus/T. kodakaraensis, respectively. It is the lysine residue within this motif that becomes carbamylated during "activation" of the enzyme, with the negatively charged aspartate and glutamate residues functioning to bind divalent cations to stabilize the carbamylated lysine (1). At this time, it is not known whether Phe-170 or residues substituted in this position are required for catalysis (1, 30). Although the deduced sequence of A. fulgidus RbcL2 is more homologous to form I large subunits, no small subunit has been detected in the genome of this organism, and residues previously shown to make contact with small subunits of the form I large subunits (11) are poorly conserved within the large subunit polypeptide of A. fulgidus RbcL2. Some of these small subunit contact residues are, however, conserved in the form II R. rubrum enzyme, which also does not have small subunits (31).

View larger version (53K):
[in this window]
[in a new window]
|
FIGURE 1. Partial amino acid sequence alignments of form III archaeal (A. fulgidus, M. jannaschii, and T. kodakaraensis) and representative form I (Synechococcus sp. strain PCC 6301) and form II (R. rubrum) Rubiscos. Multiple sequence alignments were performed using ClustalW (32). The NCBI accession numbers for each deduced large subunit gene sequence are as follows: A. fulgidus rbcL2, O28635; M. jannaschii rbcL, Q58632; T. kodakaraensis rbcL, O93627; Synechococcus (Syn) PCC 6301 rbcL, P00880; and R. rubrum cbbM, P04718. Residue identities are marked with asterisks; conserved substitutions are marked with colons; and semiconserved substitutions are marked with periods (32). Known active-site residues determined to be within 3.3 Å of the bound transition state analog 2-carboxyarabinitol 1,5-bisphosphate in the Synechococcus PCC 6301 enzyme are shown in boldface and labeled C for catalytic and R for RuBP binding properties. Where these residues are identical in all three sequences, they are highlighted in black. The characteristic Rubisco motif sequence (GXD-FXKXDE) is underlined. The conserved methionine in all form III Rubiscos (A. fulgidus Met-295), which is the focus of this study, and the corresponding residues in the form I and II enzymes are highlighted as an open box.
|
|

View larger version (86K):
[in this window]
[in a new window]
|
FIGURE 2. Coomassie Blue-stained SDS-polyacrylamide gel of samples from Rubisco purification. The A. fulgidus rbcL2 gene was expressed in E. coli, and samples were obtained from uninduced E. coli cells (lane 1), soluble extract of French press-disrupted E. coli cells after induction (lane 2), supernatant obtained after centrifugation of the heat-treated extract for 20 min at 80 °C (lane 3), Q-Sepharose anion-exchange chromatography (lane 4), Superose 12 gel filtration (lane 5), and phenyl-Sepharose hydrophobic chromatography (lane 6).
|
|
The A. fulgidus rbcL2 gene was overexpressed in E. coli BL21, and the resultant recombinant protein was purified to virtual homogeneity under strictly anaerobic conditions (Fig. 2). By nondenaturing polyacrylamide gel electrophoresis and gel filtration chromatography, purified A. fulgidus RbcL2 was found to exist as a dimer of large subunits, similar to the previously determined holoenzyme structure of form III M. jannaschii RbcL (11, 12). Like the M. jannaschii (12) and T. kodakaraensis (8) archaeal Rubiscos, the A. fulgidus enzyme was highly active at temperatures up to 93 °C, with a temperature optimum for activity of 83 °C. Interestingly, activity was detected as low as 23 °C, quite different from the M. jannaschii enzyme (12). Optimal activity for A. fulgidus RbcL2 was also achieved in the presence of 0.3 M NaCl. Under strictly anaerobic conditions at 83 °C, the expected product, 3-[14C]PGA, was produced in stoichiometric amounts by the A. fulgidus RbcL2-catalyzed reaction using a 14CO2 incorporation assay or a nonradioactive coupled PGA enzyme assay (11). These results demonstrate that this enzyme is a bona fide Rubisco. Furthermore, A. fulgidus RbcL2 was found to possess an unusually high kcat of 23 s-1 at 83 °C (specific activity of 28.9 µmol/min/mg) compared with the characteristically low kcat values of 3-5 s-1 reported for other forms of Rubisco assayed at their optimal temperatures (26, 32).

View larger version (18K):
[in this window]
[in a new window]
|
FIGURE 3. Recovery of carboxylase activity of A. fulgidus RbcL2 upon oxygen exposure. The wild-type (A) and M295D (B) enzymes were assayed initially under strictly anaerobic conditions (Anaerobic). The enzyme was then exposed to molecular oxygen for 30 min and assayed in the presence of air (Oxygen Exposed). An aliquot was taken from the vial containing oxygen-exposed enzyme, injected into an anaerobic vial, and assayed (Recovered). No O2-scavenging system was present in the "recovered" vials. Assay conditions were the same in all cases using the Rubisco assay as described under "Experimental Procedures," with the exception of the "oxygen-exposed" samples, in which the assay vials were not sealed with rubber septas and were crimped with aluminum caps.
|
|
Interactions with Molecular OxygenAside from its extreme thermostability and high intrinsic activity, A. fulgidus RbcL2, unlike its T. kodakaraensis homolog (8), was found to be sensitive to molecular oxygen. Thus, substantial activity loss was obtained in preparations exposed to oxygen and/or assayed in the presence of oxygen even in the presence of overwhelming excesses of bicarbonate. Our experiments, as well as previous studies (11, 12), indicated that the activity lost after exposure of A. fulgidus RbcL2 to molecular oxygen could be recovered. When the enzyme was exposed to molecular oxygen for 30 min and assayed in the presence of air,
10-15% of the overall carboxylase activity was obtained compared with enzyme kept fully anaerobic and assayed under strictly anaerobic conditions. When the oxygen-exposed enzyme was subsequently injected into an anaerobic vial and assayed under strictly anaerobic conditions, 65% of the carboxylase activity was obtained compared with enzyme preparations maintained and assayed under anaerobic conditions (Fig. 3A). Several repetitions of these experiments with different enzyme preparations indicated that the levels of recovered activity ranged from 65% to nearly full recovery. The fact that the level of recovered activity varied suggested that perhaps differing amounts of oxygen might have been carried over from the oxygen incubation vials to the anaerobic assay tubes. Thus, experiments were designed to scrub out all vestiges of oxygen from enzyme preparations that had been exposed to oxygen and then transferred to and diluted in the anaerobic assay vials. Scrubbing was accomplished by incorporating commercially available protocatechuate 3,4-dioxygenase and its substrate, protocatechuic acid, into the Rubisco assay mixture to "fix" any oxygen that remained in solution. The protocatechuate 3,4-dioxygenase scrubbing system was highly effective, resulting in the recovery of all available carboxylase activity (Fig. 4). O2-mediated inhibition was thus fully reversible; partial restoration (65%) of activity obtained in vials lacking the oxygen-scrubbing system was clearly attributable to oxygen carried over from the initial incubation.
Kinetics of Oxygen-mediated InhibitionInhibition by low amounts of oxygen, especially in the presence of a large excess of bicarbonate (CO2) in the otherwise anaerobic assay, is something that is not seen with the highly studied form I and II enzymes simply because CO2 and O2 compete for the same enediolate-enzyme complex. Thus, 20-50 mM bicarbonate in an assay typically simply overcomes any O2 that might otherwise inhibit the carboxylation reaction. For the A. fulgidus enzyme, a viable assumption is that oxygen binding must be quite efficient because simply diluting oxygen-exposed enzyme into an anaerobic assay with high levels of bicarbonate was not sufficient to fully reactivate the enzyme. Furthermore, full activity was restored only after the addition of the O2-scavenging system. Thus, experiments were initiated to measure the affinity of the A. fulgidus enzyme for its substrates CO2, O2, and RuBP. The usual anaerobic methods were employed as described under "Experimental Procedures," and the KCO2, KO2, and KRuBP were determined at 83 °C. The KCO2 was determined to be 51 ± 8 µM (Fig. 5). To calculate the KO2, various fixed concentrations of pure oxygen were injected into vials that were assayed with varying amounts of CO2 as described for the KCO2 determination. Double-reciprocal plots (Fig. 5, upper panel) clearly show that O2 was a competitive inhibitor with respect to CO2. In addition, replotting of the data allowed the KO2 or Ki for O2 to be determined (5 ± 1 µM) (Fig. 5, lower panel). The KRuBP was determined to be 20 ± 5 µM (Table 1). The KCO2 and KRuBP values fall within the range of values reported for other form I and II Rubiscos (2). The most notable difference was the extremely low KO2 for A. fulgidus RbcL2. Form I and II Rubiscos typically have KO2 values ranging from 500 to 1000 µM; thus, it is apparent that the unusual sensitivity of A. fulgidus RbcL2 activity to oxygen may be attributed to the extremely high affinity of this form III archaeal enzyme for oxygen.
Bioinformatic Analysis of Different Forms of RubiscoThe low residual carboxylase activity seen with the A. fulgidus enzyme in the presence of low concentrations of oxygen was also observed for other form III archaeal enzymes from M. jannaschii and M. acetivorans (11, 12). Moreover, as a result of various genome sequencing projects, there are now several available archaeal Rubisco sequences in the data base. These archaeal sequences, along with many additional form I and II Rubisco sequences available, prompted a bioinformatic analysis of all available form I-III sequences to determine whether there might be unique residues within structurally significant regions of the enzyme that might perhaps influence the unusual kinetic properties of the archaeal Rubisco.
Eight known form III Rubiscos from Archaea, A. fulgidus RbcL2, T. kodakaraensis (NCBI accession number AB018555
[GenBank]
), M. jannaschii (AAB99239
[GenBank]
), M. acetivorans (AAM07894
[GenBank]
), Methanosarcina mazei (AAM30945
[GenBank]
), Pyrococcus abyssi (CAB50122
[GenBank]
), Pyrococcus furiosus (AAL81280
[GenBank]
), and Pyrococcus horikoshii (BAA30036
[GenBank]
), were aligned using ClustalW (33). Of the 441 amino acids in A. fulgidus RbcL2, there are 107 amino acids that are identical among the eight archaeal Rubiscos. To determine the uniqueness of these 107 amino acids, all eight form III Rubisco sequences were compared with a large representative group of form I and II Rubiscos. Of the 107 amino acids, 55 of these differed from the form I and II proteins. These 55 amino acids were then examined with respect to their positions within the crystal structures of representative form I (Synechococcus PCC 6301) and form II (R. rubrum) Rubiscos as well as to a homology model of the structure of dimeric A. fulgidus RbcL2. Of these 55 amino acid differences, Met-295 of the protein was of particular interest because of its position within the A. fulgidus RbcL2 model structure as well as because of changes in this residue in form I and II Rubiscos.
Site-directed Mutagenesis and Properties of Altered EnzymesMet-295 of the A. fulgidus rbcL2 gene was altered according to established site-directed mutagenesis protocols, with the recombinant M295F mutant A. fulgidus protein synthesized and purified to mimic the form I enzymes at this position and the M295A protein produced to mimic the form II enzymes. Finally, a recombinant M295D enzyme was synthesized and purified to introduce a charged amino acid that is not present at this position in any of the three forms of Rubisco. All three mutant proteins (M295A, M295D, and M295F) were initially analyzed in extracts prepared from small-scale cultures (25 ml) along with the wild-type enzyme, produced from cells grown under exactly the same conditions. Large-scale growths were also performed to obtain greater amounts of protein when required (see "Experimental Procedures"). For these initial assays, anaerobically prepared heat-treated supernatant fractions were used as the source of enzyme because significant amounts of heat-labile E. coli proteins could be removed (Fig. 2). Each sample was assayed under strictly anaerobic conditions to monitor activity; an aliquot of the enzyme preparation was then exposed to molecular oxygen and re-assayed. The wild-type, M295A, and M295F enzymes each had 11-17% activity compared with anaerobic controls. Surprisingly, the M295D enzyme showed the least sensitivity to oxygen exposure and retained 35% of its activity after the same oxygen exposure regimen.
These results prompted additional studies of the M295D enzyme; accordingly, large-scale growths allowed significant amounts of purified recombinant protein to be prepared, much like the recombinant wild-type enzyme (Fig. 2). Purified wild-type and M295D proteins were assayed both anaerobically and aerobically after 30 min of exposure to oxygen. Although the purified wild-type enzyme again showed 85-90% loss of activity upon oxygen exposure and assay in the presence of air, the M295D enzyme lost only 60-65% of its activity (Fig. 3B), similar to results obtained with the partially purified M295D protein. Clearly, the M295D enzyme was altered in such a way that the normal response to molecular oxygen was changed; this enzyme appeared much less susceptible to the deleterious effects of oxygen. As with the wild-type enzyme (Fig. 5), the kinetic constants for each of the substrates (KCO2, KO2, and KRuBP) were determined for the M295D enzyme at 83 °C (Table 1). Clearly, there was little change in the KCO2 and KRuBP for the M295D enzyme. However, in agreement with the recovery experiment, there was an
5-fold increase in the KO2 (from 5 ± 1 µM for the wild-type enzyme to 24 ± 7 µM determined for the M295D protein). Although double-reciprocal plots at varying CO2 concentrations and several fixed O2 levels for the M295D enzyme (Fig. 6, upper panel) showed more scatter than for the wild-type enzyme (Fig. 5), replots of the data gave a linear response (Fig. 6, lower panel) such that accurate and reproducible kinetic constants could be determined. Again, the M295D enzyme showed the expected competitive inhibition by O2 with respect to CO2. Furthermore, the M295D enzyme retained significantly more activity than did the wild-type enzyme when both enzymes were incubated with concentrations of oxygen ranging from 1 to 100% in the gas phase (data not shown). Like the wild-type enzyme (Fig. 4), the M295D enzyme recovered fully after the oxygen-exposed enzyme was incubated in anaerobic vials containing the oxygen-scrubbing system to remove carryover oxygen from the incubation vials.

View larger version (13K):
[in this window]
[in a new window]
|
FIGURE 7. Anion-exchange chromatographic separation of Rubisco reaction products. 3-[3H]PGA and 2-[3H]PG were generated from a completed reaction mixture containing [1-3H]RuBP after a 2-h reaction at 83 °C. A and B, wild-type and M295D A. fulgidus Rubiscos, respectively, were incubated in the presence of both molecular oxygen and CO2 to generate 3-[3H]PGA and 2-[3H]PG. C, wild-type A. fulgidus RbcL2 was incubated in the absence of O2 in the presence of CO2 for 2 h at 83 °C to allow the generation of only 3-[3H]PGA. Peaks at the beginning of each chromatographic profile represent degraded RuBP produced in this reaction mixture at high temperatures. Peaks at the end of each profile represent RuBP reduction products produced after the addition of NaBH4 to quench the reaction in the absence of enzyme (20).
|
|
The low residual activity that was retained by the wild-type A. fulgidus enzyme upon exposure to oxygen suggested that it would be feasible to determine the CO2/O2 specificity of the enzyme, i.e. the specificity factor (
). Thus, experiments were performed with both the wild-type and M295D enzymes using established methods to separate and quantitate the specific carboxylase and oxygenase reaction products (3-[3H]PGA and 2-[3H]PG, respectively) obtained from a reaction mixture containing [1-3H]RuBP and both gaseous substrates CO2 and O2 (22). The results of this experiment indicated that the wild-type A. fulgidus RbcL2 enzyme catalyzed, albeit weakly and over a long time period, oxygen-dependent formation of 2-[3H]PG (Fig. 7A), which was not formed in the absence of oxygen (Fig. 7C). Clearly, comparisons of the chromatographic profiles in the presence and absence of oxygen indicated that the level of 3-[3H]PGA produced was greatly reduced under an oxygen atmosphere, in agreement with the 14CO2 incorporation assays showing inhibition of carboxylase activity in the presence of oxygen. In addition, it was apparent that the M295D enzyme produced significantly more 3-[3H]PGA than did the wild-type enzyme (Fig. 7B). Presumably, the increase in the KO2 or Ki for O2 for the M295D enzyme impinges on the fact that the carboxylation reaction is less inhibited in the presence of oxygen compared with the wild-type enzyme. The levels of 3-[3H]PGA and 2-[3H]PG produced at the concentrations of O2 and CO2 utilized in this reaction allowed a calculation to be made of the relative CO2/O2 substrate specificity factor (
) value for this archaeal enzyme and the M295D mutant protein (Table 1). The consequences of enhanced carboxylase activity in the presence of oxygen for the M295D enzyme and the increase in the KO2 caused an
3-fold increase in the
value compared with the wild-type protein.

View larger version (19K):
[in this window]
[in a new window]
|
FIGURE 8. Wild-type and mutant A. fulgidus RbcL2 activities after exposure to oxygen. Purified recombinant wild-type, M295D, S363I, S363V, M295D/S363I, and M295D/S363V enzymes were assayed for activity under strictly anaerobic conditions. These preparations were then exposed to pure oxygen as described under "Experimental Procedures" and assayed in the presence of air. The percent activity retained is the amount of carboxylase activity obtained under anaerobic conditions compared with the amount of carboxylase activity obtained after oxygen exposure and assay in the presence of air. Absolute specific activities (nanomoles of CO2 fixed per min/mg) obtained under both conditions are listed below each sample.
|
|
To assess whether the role of the methionine-to-aspartic acid substitution at position 295 in the enzyme might be unique, substitutions were considered at other positions in close proximity to the active site. Similar to how Met-295 is positioned with regard to the active site, Ser-363,
10 Å from Met-295 according to the modeled structure, is situated in what appears to be a hydrophobic pocket that surrounds one side of the active site. In addition, the model structure shows an ionic interaction of the side chain of Ser-363 with the highly conserved and catalytically important residues Gly-313 and Thr-314 of A. fulgidus RbcL2. Gly-313 and Thr-314, found in all forms of Rubisco, show no ionic interactions with the amino acid residue equivalent to Ser-363 of RbcL2 in form I and II enzymes. This unique interaction and positioning of Ser-363 in a key hydrophobic pocket of RbcL2, similar to Met-295, thus suggested that Ser-363 of RbcL2 might be a likely candidate for further investigation by site-directed mutagenesis. Sequence alignments of form I-III enzymes show that alanine is uniquely conserved at this position in the form I enzymes and that isoleucine is uniquely conserved at this same position in the form II enzymes. In the form III enzymes, serine is present at this position for A. fulgidus, T. kodakaraensis, and M. jannaschii, whereas the remaining methanogens and all of the pyrococci have alanine present at this position. Because of the residues found at this position in the above enzymes, Ser-363 was changed to alanine, isoleucine, or valine in A. fulgidus RbcL2. Initial analysis of heat-stable extracts as well as purified S363I and S363V enzymes indicated that recombinant RbcL2 mutated in this position exhibited less oxygen sensitivity compared with the wild-type enzyme. However, the S363A enzyme did not show a change in oxygen sensitivity compared with the wild-type enzyme. The S363I and S363V enzymes retained 48 and 42% activity when exposed to oxygen compared with the enzyme assayed under anaerobic conditions (Fig. 8). Clearly, these two mutants had a similar effect on oxygen sensitivity as the M295D enzyme, perhaps indicating that substitutions at Met-295 do not merely eliminate some chemical modification or oxidation effect of the methionine side chain. To further probe the importance of the mutations at Met-295 and Ser-363, double mutants were constructed and analyzed. When exposed to oxygen, the M295D/S363I and M295D/S363V enzymes retained even higher levels of activity compared with the single mutants, i.e. 82% activity was retained for the M295D/S363I enzyme and 86% activity for the M295D/S363V enzyme (Fig. 8). However, as a consequence of changing these two residues near the active site, the absolute activity levels (specific activities or kcat) of these two double mutants were much lower than those of the wild-type and single mutant enzymes.
 |
DISCUSSION
|
|---|
A previous study demonstrated, via 14CO2 radiometric assays and Western immunoblotting, that crude cell extracts of A. fulgidus do indeed contain functional Rubisco (12). Because A. fulgidus is a thermophilic strict anaerobe isolated from the bottom of the ocean near hydrothermal vents, it is not surprising that Rubisco from this organism adapts to function under similar extreme conditions in vitro. Indeed, this form III homodimer catalyzes a reaction with a kcat that is 4-5-fold higher than other forms of Rubisco. Of considerable interest (and unlike other well studied Rubiscos) is the substantial loss of carboxylase activity of the A. fulgidus enzyme in the presence of molecular oxygen even when CO2 levels are in great excess. This was found to be a reversible effect, and in this study, it was shown that full activity could be recovered as long as all vestiges of oxygen were removed form the reaction mixture. Thus far, this response to oxygen has been observed only for certain form III archaeal Rubiscos, including the enzymes from both mesophilic and thermophilic methanogenic Archaea such as M. jannaschii and M. acetivorans (12). The ability to isolate substantial amounts of purified recombinant A. fulgidus protein, coupled with the recent determination of the structure of the related Rubisco from T. kodakaraensis (29), suggested that it might be feasible to design experiments to elucidate the molecular basis for the unusual properties exhibited by the A. fulgidus enzyme. Of particular interest is the extremely high kcat and oxygen sensitivity of this enzyme. The response to molecular oxygen was clearly shown to be a classic competition with CO2 for the enediolate intermediate of the enzyme, as observed for all Rubisco proteins. However, what distinguished the A. fulgidus enzyme from other sources of Rubisco was the extremely high affinity this enzyme showed for molecular oxygen, with Ki values (
5 µM) that were nearly 3 orders of magnitude lower than those of typical form I or II enzymes. Clearly, this high affinity for molecular oxygen underscores why inhibition of carboxylase activity was initially obtained even in reaction mixtures that contained levels of CO2 that normally overcomes the inhibitory effects of oxygen on form I and II Rubiscos.

View larger version (66K):
[in this window]
[in a new window]
|
FIGURE 9. Quaternary structure prediction of A. fulgidus RbcL2. The predicted structure of the A. fulgidus RbcL2 protein was modeled on the known structure of the T. kodakaraensis strain KOD1 RbcL protein (Protein Data Bank code 1GEH) using DeepView Swiss-PdbViewer Version 3.7. The ribbon models of the two monomers are shaded cyan and orange, respectively. Within each monomer, the main features are the catalytically important residues (colored red) predicted to be within 3.3 Å of a bound five-carbon transition state molecule, shown to be positioned in the same areas as in other Rubisco enzymes. The first nine amino acids were not predicted and thus are not part of the model structure.
|
|

View larger version (63K):
[in this window]
[in a new window]
|
FIGURE 10. Predicted side chain interactions with Met-295 in the wild-type and M295D mutant A. fulgidus RbcL2 enzymes. The side chains of Met-295 (A) and Asp-295 (B) are shown, as well as conserved amino acids found in all other forms of Rubisco. In the wild-type and M295D mutant A. fulgidus RbcL2 enzymes, His-278, Arg-279, and His-311 are illustrated, as they are necessary for catalysis and binding of the five-carbon substrate RuBP. The model structure predicts no ionic interactions between Arg-279 and Met-295 in the wild-type form of the enzyme (A). In the M295D mutant, the model predicts an ionic interaction between the hydroxyl group of Asp-295 and the amino group of Arg-279 (broken purple line).
|
|
Obviously, Rubisco from organisms like A. fulgidus is not ever expected to encounter molecular oxygen. With the interesting in vitro response of this enzyme to oxygen noted in this study, we proceeded to further analyze this protein with expectations that such studies might eventually provide clues as to how the active site of Rubisco evolved in more evolutionary advanced organisms. In our analysis of the linear sequences of the A. fulgidus (and other archaeal) Rubiscos compared with those of other well studied form I and II enzymes, Met-295 was singled out for further attention. After this residue was altered by site-directed mutagenesis, and recombinant M295A, M295D, and M295F proteins were prepared, it was apparent that the M295D enzyme showed substantially less sensitivity to molecular oxygen than did the wild-type protein. A homology model of the homodimeric structure of A. fulgidus RbcL2 was constructed (Fig. 9) based on the solved structure of the highly homologous (72% amino acid identity) T. kodakaraensis enzyme (29). Like the large subunits of all Rubiscos, known residues necessary for catalysis (1) are conserved and are positioned within the A. fulgidus structure in the same locale as in other Rubisco structures. As for Met-295, it was found to be situated in a hydrophobic pocket created by residues along the active site and in close proximity to a highly conserved residue, Arg-279 (Figs. 1 and 10), found in all other forms of Rubisco and shown to be necessary for substrate (RuBP) binding (34). In A. fulgidus RbcL2, there is no hydrogen bond to Arg-279 (Fig. 10A). However, there is definite hydrogen bonding to the equivalent Arg residue in all other form I and II Rubisco structures, e.g. originating from the oxygen atom of the carbonyl group of His-324 from the peptide backbone of the Synechococcus PCC 6301 enzyme. In the A. fulgidus RbcL2 model, the distance between the corresponding arginine residue (Arg-279) and the carbonyl group of the equivalent histidine (His-311) of the peptide backbone is
3.70 Å. The model structure suggests that mutation of Met-295 to aspartate would allow for an ionic interaction between one of the hydroxyl side chains of the aspartate residue with one of the side chain nitrogen atoms of Arg-279 (Fig. 10B). All other amino acid mutations made at position 295 suggested either unfavorable conformations or no ionic interactions with Arg-279. In addition, many rotamers were available for the aspartic acid substitution at the methionine position; the rotamers with the lowest score, thus the most favorable conformation, all had hydrogen bond interactions with Arg-279. Although this occurrence is seen within the model structure, perhaps stabilization of Arg-279 is necessary for the carboxylation activity to function in the presence of oxygen, or perhaps there is some significance to the presence of hydrophobic pockets surrounding the active site. Thus, the amino acid side chain situated in these pockets might play a role in the enzyme's overall carboxylation activity in the presence of oxygen, as demonstrated for Met-295. This could perhaps be the reason why hydrogen bonding is observed at a different position in other solved crystal structures, but not in the model of A. fulgidus RbcL2. Further investigation into this localized structural change led us to another amino acid, Ser-363, which we predicted might have a similar effect on oxygen sensitivity. A possible alteration of the hydrogen bond interactions with the highly conserved Arg-279, independent of the suggested hydrogen bonding between M295D and Arg-279, might be influenced by mutations to Ser-363. Again, the model structure indicates that this amino acid is on
-strand 7, situated in a hydrophobic pocket adjacent to the active site. Alanine is strictly conserved at this same position in the form I enzymes, and isoleucine in the form II enzymes. Form III enzymes have either serine or alanine. For A. fulgidus RbcL2, the S363I and S363V mutant enzymes showed increased retention of activity when assayed in the presence of oxygen, whereas the S363A mutant enzyme mimicked the wild-type enzyme and lost activity when assayed in the presence of oxygen. These results were quite reminiscent of what was found for enzymes containing substitutions at Met-295. Additionally, the recombinant M295D/S363I and M295D/S363V double mutants retained very high levels of activity when assayed in the presence of oxygen, suggesting an additive effect of mutations at two influential residues in hydrophobic pockets situated close to the active site. The mutations at Ser-363 and the double mutations of M295D and the Ser-363 mutants will prompt further investigations of these interactions and how they influence the activity of the enzyme and, more importantly, the interaction with molecular oxygen. In addition, the potential to biologically select (20) double mutants that retain high absolute activity is something that might be quite feasible and most revealing.
 |
FOOTNOTES
|
|---|
* This work was supported by Grant GM24497 from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 
1 To whom correspondence should be addressed: Dept. of Microbiology, Ohio State University, 484 W. 12th Ave., Columbus, OH 43210-1292. Tel.: 614-292-4297; Fax: 614-292-6337; E-mail: tabita.1{at}osu.edu.
2 The abbreviations used are: CBB, Calvin-Benson-Basham; Rubisco, ribulose-1,5-bisphosphate carboxylase/oxygenase; RuBP, ribulose 1,5-bisphosphate; 3-PGA, 3-phosphoglycerate; 2-PG, 2-phosphoglycolate; Bicine, N,N-bis(2-hydroxyethyl)glycine. 
 |
ACKNOWLEDGMENTS
|
|---|
We thank the staff of the Plant-Microbe Genomics Facility for automated DNA sequencing and Cedric Bobst and Sriram Satagopan for discussions and technical advice.
 |
REFERENCES
|
|---|
- Cleland, W. W., Andrews, T. J., Gutteridge, S., Hartman, F. C., and Lorimer, G. H. (1998) Chem. Rev. 98, 549-562[CrossRef][Medline]
[Order article via Infotrieve]
- Tabita, F. R. (1999) Photosynth. Res. 60, 1-28
- Ellis, R. J. (1979) Trends Biochem. Sci. 4, 241-244[CrossRef]
- Jordan, D. B., and Ogren, W. L. (1981) Nature 291, 513-515[CrossRef]
- Horken, K. M., and Tabita, F. R. (1999) Arch. Biochem. Biophys. 361, 183-194[CrossRef][Medline]
[Order article via Infotrieve]
- Spreitzer, R. J. (1999) Photosynth. Res. 60, 29-42
- Deppenmeier, U., Johann, A., Hartsch, T., Merkl, R., Schmitz, R. A., Martinez-Arias, R., Henne, A., Wiezer, A., Baumer, S., Jacobi, C., Bruggemann, H., Lienard, T., Christmann, A., Bomeke, M., Steckel, S., Bhattacharyya, A., Lykidis, A., Overbeek, R., Klenk, H. P., Gunsalus, R. P., Fritz, H. J., and Gottschalk, G. (2002) J. Mol. Microbiol. Biotechnol. 4, 453-461[Medline]
[Order article via Infotrieve]
- Ezaki, S., Maeda, N., Kishimoto, T., Atomi, H., and Imanaka, T. (1999) J. Biol. Chem. 274, 5078-5082[Abstract/Free Full Text]
- Galagan, J. E., Nusbaum, C., Roy, A., Endrizzi, M. G., MacDonald, P., FitzHugh, W., Calvo, S., Engels, R., Smirnov, S., Atnoor, D., Brown, A., Allen, N., Naylor, J., Stange-Thomann, N., DeArellano, K., Johnson, R., Linton, L., McEwan, P., McKernan, K., Talamas, J., Tirrell, A., Ye, W., Zimmer, A., Barber, R. D., Cann, I., Graham, D. E., Grahame, D. A., Guss, A. M., Hedderich, R., Ingram-Smith, C., Kuettner, H. C., Krzycki, J. A., Leigh, J. A., Li, W., Liu, J., Mukhopadhyay, B., Reeve, J. N., Smith, K., Springer, T. A., Umayam, L. A., White, O., White, R. H., Conway de Macario, E., Ferry, J. G., Jarrell, K. F., Jing, H., Macario, A. J., Paulsen, I., Pritchett, M., Sowers, K. R., Swanson, R. V., Zinder, S. H., Lander, E., Metcalf, W. W., and Birren, B. (2002) Genome Res. 12, 532-542[Abstract/Free Full Text]
- Klenk, H. P., Clayton, R. A., Tomb, J. F., White, O., Nelson, K. E., Ketchum, K. A., Dodson, R. J., Gwinn, M., Hickey, E. K., Peterson, J. D., Richardson, D. L., Kerlavage, A. R., Graham, D. E., Kyrpides, N. C., Fleischmann, R. D., Quackenbush, J., Lee, N. H., Sutton, G. G., Gill, S., Kirkness, E. F., Dougherty, B. A., McKenney, K., Adams, M. D., Loftus, B., Peterson, S., Reich, C. I., McNeil, L. K., Badger, J. H., Glodek, A., Zhou, L., Overbeek, R., Gocayne, J. D., Weidman, J. F., McDonald, L., Utterback, T., Cotton, M. D., Spriggs, T., Artiach, P., Kaine, B. P., Sykes, S. M., Sadow, P. W., D'Andrea, K. P., Bowman, C., Fujii, C., Garland, S. A., Mason, T. M., Olsen, G. J., Fraser, C. M., Smith, H. O., Woese, C. R., and Venter, J. C. (1997) Nature 390, 364-370[CrossRef][Medline]
[Order article via Infotrieve]
- Watson, G. M. F., Yu, J., and Tabita, F. R. (1999) J. Bacteriol. 181, 1569-1575[Abstract/Free Full Text]
- Finn, M., and Tabita, F. R. (2003) J. Bacteriol. 185, 3049-3059[Abstract/Free Full Text]
- Finn, M., and Tabita, F. R. (2004) J. Bacteriol. 186, 6360-6366[Abstract/Free Full Text]
- Watson, G. M. F., and Tabita, F. R. (1997) FEMS Microbiol. Lett. 146, 13-22[CrossRef][Medline]
[Order article via Infotrieve]
- Tabita, F. R., and McFadden, B. A. (1974) J. Biol. Chem. 249, 3459-3464[Abstract/Free Full Text]
- Yanisch-Perron, C., Vieira, J., and Messing, J. (1985) Gene (Amst.) 33, 103-119[CrossRef][Medline]
[Order article via Infotrieve]
- Papworth, C., Bauer, J. C., Braman, J., and Wright, D. A. (1996) Strategies 9, 3-4
- Tabita, F. R., Caruso, P., and Whitman, W. (1978) Anal. Biochem. 84, 462-472[CrossRef][Medline]
[Order article via Infotrieve]
- Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline]
[Order article via Infotrieve]
- Smith, S., and Tabita, F. R. (2003) J. Mol. Biol. 331, 557-569[CrossRef][Medline]
[Order article via Infotrieve]
- Dean, J. A. (ed) (1985) Lange's Handbook of Chemistry, 13th Ed., McGraw-Hill Book Co., New York
- Harpel, M. R., Lee, E. H., and Hartman, F. C. (1993) Anal. Biochem. 209, 367-374[CrossRef][Medline]
[Order article via Infotrieve]
- Guex, N., and Peitsch, M. C. (1997) Electrophoresis 18, 2714-2723[CrossRef][Medline]
[Order article via Infotrieve]
- Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindvalov, I. N., and Bourne, P. E. (2000) Nucleic Acids Res. 28, 235-242[Abstract/Free Full Text]
- Gutteridge, S., and Gatenby, A. A. (1995) Plant Cell 7, 809-819[CrossRef][Medline]
[Order article via Infotrieve]
- Hartman, F. C., and Harpel, M. R. (1994) Annu. Rev. Biochem. 63, 197-234[CrossRef][Medline]
[Order article via Infotrieve]
- Lundqvist, T., and Schneider, G. (1991) J. Biol. Chem. 266, 12604-12611[Abstract/Free Full Text]
- Newman, J., and Gutteridge, S. (1993) J. Biol. Chem. 268, 25876-25886[Abstract/Free Full Text]
- Maeda, N., Kitano, K., Fukui, T., Ezaki, S., and Imanaka, T. (1999) J. Mol. Biol. 293, 57-66[CrossRef][Medline]
[Order article via Infotrieve]
- Andersson, I., Knight, S., Schneider, G., Lindqvist, Y., Lundqvist, T., Branden, C.-I., and Lorimer, G. H. (1989) Nature 337, 229-234[CrossRef]
- Tabita, F. R., and McFadden, B. A. (1974) J. Biol. Chem. 249, 3459-3466[Abstract/Free Full Text]
- Hartman, F. C., and Harpel, M. R. (1993) Adv. Enzymol. Relat. Areas Mol. Biol. 6, 71-75
- Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1989) Nucleic Acids Re